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Abstract 
Nucleosides and their analogues play a crucial role in the treatment of several diseases including cancers 
and viral infections. Their therapeutic efficiency depends on their capacity to be converted to the active 
nucleoside triphosphates form through successive phosphorylation steps catalyzed by 
nucleoside/nucleotide kinases. It is thus mandatory to develop an easy, rapid, reliable and sensitive 
enzyme activity tests. In this study, we monitored the three-step phosphorylation of thymidine to 
thymidine triphosphate respectively by (1) human thymidine kinase 1 (hTK1), (2) human thymidylate 
kinase (hTMPK) and (3) human nucleoside diphosphate kinase (hNDPK). Free and immobilized kinase 
activities were characterized by using the Michaelis-Menten kinetic model. Flow Injection Analysis 
(FIA) with High-Resolution Mass Spectrometry (HRMS) was used as well as capillary electrophoresis 
(CE) with UV detection. The three-step cascade phosphorylation of thymidine was also monitored. FIA-
HRMS allows a sensitive and rapid evaluation of the phosphorylation process. This study proposes 
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simple, rapid, efficient and sensitive methods for enzyme kinetic studies and successive phosphorylation 
monitoring with immobilized enzymes. 
Keywords: Capillary electrophoresis, Drug discovery, FIA-HRMS, Immobilized Kinases, Michaelis-
Menten, Multi-step enzymatic cascade phosphorylation. 
 
1. Introduction 
The development of new drugs is a long time process. The accumulation of active or toxic substances 
could have an important impact on pharmacological and toxicological outcomes. Metabolic pathway of 
pharmaceutical drugs is an important aspect in drug discovery. Monitoring drug conversion (or non-
conversion), mainly when successive enzymatic reactions are involved, brings better understanding of 
drug activity and toxicity. Therefore, good understanding of metabolic pathways helps to optimize drug 
development. In this work, the phosphorylation of some nucleosides and their analogues was studied in 
order to illustrate this statement. These compounds are the cornerstone of the treatment of several human 
diseases and are especially at the forefront of antiretroviral therapy. Once converted to their triphosphate 
counterparts they can exhibit their biological activity by incorporating viral DNA due to the action of 
the viral DNA polymerase. This can cause DNA chain termination, preventing virus proliferation [1-5]. 
The phosphorylation process of a nucleoside to its triphosphate counterpart involves three successive 
enzymatic phosphorylation reactions [6]. For instance, the conversion of thymidine (dT) to thymidine 
triphosphate (dTTP) can be catalyzed by human thymidine kinase (hTK1), human thymidylate kinase 
(hTMPK) and human nucleoside diphosphate kinase (hNDPK), respectively. These enzymes catalyze 
the phosphotransfer of the γ-phosphate of adenosine-5’-triphosphate (ATP) in the presence of a 
chelating agent, usually MgCl2 (Figure 1) [7]. The phosphorylation of nucleosides and nucleotides is 
highly compound dependent, and the first phosphorylation step is often rate-limiting [8]. 
Enzymatic cascade reactions are of great interest in drug discovery. They are sometimes easily 
conducted with the use of immobilized enzymes (stepwise immobilized enzymes, mixed immobilized 
enzymes and co-immobilized enzymes) [9-12], on various supports [13-16]. The use of immobilized 
enzymes for the study of enzymatic cascades has already been investigated [9, 11, 17].  
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To the best of our knowledge, the phosphorylation cascade process of a nucleoside into its triphosphate 
counterpart has not been investigated. Previous published studies mainly focused only on a single step 
of the phosphorylation process. The main techniques used for this are spectrophotometry [18, 19], 
radioisotopy [20, 21], high performance liquid chromatography [22] and capillary electrophoresis [23-
25]. Assays conducted by spectrophotometry are based on the detection of ATP consumption. Even 
though widely used, this procedure suffers from a low sensitivity, a high substrate and enzyme 
consumptions, and a low robustness. Separative techniques may necessitate lengthy analyses and 
specific separation method for each kind of analysed molecules. Electrospray ionization mass 
spectrometry (ESI-MS), which is widely used for phosphorylated molecule analysis [26-28], is of 
general interest for application in drug discovery [29-33]. Mass spectrometer can be considered as a 
detector of choice for the study of enzymatic activity [34-38]. Its high sensitivity and detection 
specificity (exhaustive fingerprint) allows rapid and sensitive analysis after direct injection of enzymatic 
reaction mixtures without any prior separation. 
A first part of this study was dedicated to develop a rapid, direct and simple kinase activity 
characterization by FIA-HRMS methodology. Validation of the developed method was performed by 
studying free hTMPK activity by FIA-HRMS. The Michaelis-Menten parameters (determination of KM 
and Vmax) [39] obtained with UV-spectrophotometry and capillary electrophoresis (CE using UV 
detection) were compared with those obtained by FIA-HRMS. The FIA-HRMS methodology was then 
evaluated for monitoring the three successive phosphorylation steps of thymidine using free enzymes as 
well as enzymes immobilized on magnetic nanoparticles. 
2. Material and methods 
2.1. Material 
Adenosine 5′-triphosphate magnesium salt (ATP), thymidine (dT), thymidine 5′-monophosphate 
disodium salt hydrate (dTMP), thymidine 5′-diphosphate sodium salt (dTDP), thymidine 5′-triphosphate 
sodium salt (dTTP), ammonium acetate and magnesium chloride were purchased from Sigma-Aldrich. 
Magnetic nanoparticles, which consisted of core-shell silica-coated iron oxide magnetic nanoparticles, 
were synthesized in our laboratory as previously described by our group [40]. Plasmids bearing hTMPK 
and recombinant hTK1 and hNDPK were a generous gift from University Pierre et Marie Curie 
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(UPMC). Recombinant hTMPK was produced and purified as described previously [41]. Briefly, cells 
transformed with the hTMPK-pET28 plasmid were grown at 37 °C in Luria broth (LB) containing            
30 µg mL-1 of kanamycin and 34 µg mL-1 of chloramphenicol for 6 h 40 min until optical density E600 = 
0.602. After induction with 400 µM of isopropyl thio-β-D-thiogalactopyranoside and growth for 3 h at 
30 °C, cells were harvested, re-suspended in 20 mL of lysis buffer Tris/HCl 100 mM ionic strength, pH 
= 8.0 containing NaCl 40 mM and 2 mM DTT, and kept at -20 °C. Cells were suspended in a Tris/HCl 
50 mM ionic strength, pH = 8 containing 1 µM DTT, 1 µM lysozyme, and 1 % PMSF (v/v). The solution 
was homogenized for 20 min at 4 °C. Cells were suggested to three thermal shocks (liquid nitrogen / 
water bath 37 °C) and 6 cycles of sonication (cycle 50 %, power 5, 30 s between each cycle). The 
supernatant was added onto a nickel column pre-equilibrated with 10 mL lysis buffer. The protein was 
manually eluted with 6 mL of lysis buffer containing 200 mM imidazole. The protein was pure as judged 
by 14 % SDS-PAGE. Protein concentration was determined using Bio-Rad Protein assay and absorbance 
at 595 nm. The protein was stocked in 50 % glycerol buffer at -80 °C at 2 mg mL-1. 
2.2. Instrumentation 
Mass spectrometry experiments were performed on a Bruker maXis UHR-Q-TOF spectrometer 
(Bremen, Germany) in negative ion mode. The mass spectrometer was coupled on-line with a Dionex 
UltiMate 3000 RSLC (ultra-high-performance liquid chromatography, UHPLC) system (Germering, 
Germany). Before each experiment, calibration was performed using ES-TOF tuning mix (Agilent). MS 
parameters were optimized to enhance ionization and to minimize in-source fragmentation of dTDP and 
dTTP (Figure S1). The capillary voltage was set at - 4000 V, the nebulizer pressure at 0.6 bar, the dry 
gas flow at 7.0 L min-1 and heated at 200 °C. One µL of sample was injected in Flow Injection Analysis 
(FIA-HRMS) mode at 200 µL min-1 using H2O/ACN 65/35 (v/v) as mobile phase. For all experiments, 
mass spectra in negative mode were recorded in the range of m/z 50 to 1350. Extracted Ion 
Chromatograms (EIC) of dT (m/z 241.0838, [M-H]-), dTMP (m/z 321.0482, [M-H]-), dTDP (m/z 
401.0145, [M-H]-), and dTTP (m/z 480.9808, [M-H]-) were plotted within ± 0.005 m/z. All data were 
analyzed using DataAnalysis 4.4 software (Bruker).  
The capillary electrophoresis system used was a PA800+ automated CE instrument from AB Sciex 
(Brea, CA, USA) equipped with a photodiode array detection system. The control of CE was performed 
5 
 
using 32 Karat software. Uncoated fused-silica capillaries (60 cm x 50 µm), purchased from Polymicro 
Technologies (Phoenix, AZ, USA) were used. New capillaries were conditioned by performing 
successive rinse cycles: 1 M NaOH (10 min) and Back Ground Electrolyte (BGE) ammonium acetate 
(80 mM ionic strength, pH = 9) for 30 min. At the end of each working day, the capillary was rinsed 
with water (10 min) to ensure good cleaning. Between analyses, the capillary was rinsed with BGE. All 
rinse cycles were carried out at 50 psi. Hydrodynamic injections were performed at the anodic side of 
the capillary (0.5 psi, 10 s). Normal polarity was used with a separation voltage of +15 kV. 
Electrophoretic separations were performed at 37 °C in the BGE. Detection was performed at 254 nm. 
2.3. Validation of FIA-HRMS methodology for kinase activity characterization using free 
enzymes 
2.3.1. Influence of MgCl2 and ATP concentrations on kinase efficiencies 
Six solutions of 25 µM of dT, dTMP and dTDP, were prepared with three concentrations of ATP (50, 
150 and 350 µM) and MgCl2 (25, 200 and 400 µM), in ammonium acetate buffer (50 mM ionic strength, 
pH = 7). Solutions were respectively incubated with free hTK1 (0.48 g L-1), free hTMPK (0.04 g L-1) 
and free hNDPK (0.04 g L-1) in a heating block at 37 °C for 30 min. One µL of each solution was injected 
as previously described. Each solution was performed in triplicate. 
2.3.2. Linearity in dependence of time 
hTK1 (0.0875 g L-1), hTMPK (0.004 g L-1) and hNDPK (0.002 g L-1) kinetics were determined by 
monitoring the accumulation of dTMP, dTDP and dTTP over the time (EIC(dTMP): m/z 321.0482, 
EIC(dTDP): m/z 401.0145, EIC(dTTP): m/z 480.9808) by FIA-HRMS. Enzymatic reactions were conducted 
at 37 °C in an Eppendorf tube placed in an HPLC autosampler. dT (10 µM), dTMP (10 µM) or dTDP 
(2 µM) were incubated in ammonium acetate (50 mM ionic strength, pH = 7) containing ATP (350 µM) 
and MgCl2 (200 µM). 12 successive injections were programmed over 6 minutes. 
2.3.3. Enzymatic assays - Determination of kinetic parameters  
FIA-HRMS based assays: 9 dT solutions (from 0 to 15 000 µM), 10 dTMP solutions (from 0 to 500 
µM) and 9 dTDP solutions (from 0 to 500 µM) were respectively incubated with hTK1 (0.0875 g L-1), 
hTMPK 0.004 g L-1 and hNDPK (0.002 g L-1) ([ATP] = 350 µM, [MgCl2] = 200 µM). Samples were 
placed in a heating block at 37 °C. After 5 min, reactions were stopped by heating at 95 °C for 5 min. 
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Each Michaelis-Menten assay was conducted in triplicate. The feasibility of kinase activity 
characterization by FIA-HRMS was evaluated by hTMPK characterization (fresh enzyme) with two 
complementary techniques, spectrophotometry and CE-UV. 
UV-spectrophotometry (λ = 340 nm) assays: hTMPK reactions were performed by mixing Tris-HCl 
buffer (50 mM ionic strength, pH = 7.4), KCl 50 mM, MgCl2 10 mM (or MgCl2 200 µM), NADH 0.2 
mM, dithiothreitol 1 mM, phosphoenolpyruvate 1 mM, pyruvate kinase 4U, lactate dehydrogenase 4U, 
ATP 5 mM (or 350 µM). Reactions were initiated at 37 °C with hTMPK addition (0.004 g L-1) and 
dTMP substrate (from 2 mM to 500 mM, 9 points). Curves were fitted with Michaelis-Menten equation 
with GraphPad Prism 5.0 software. 
Capillary electrophoresis based assays: hTMPK reactions were conducted at 37 °C in an Eppendorf tube 
by placing dTMP solutions (from 0 to 800 µM, ammonium acetate 50 mM ionic strength, pH = 7) with 
hTMPK (final concentration 0.004 g L-1), ATP (350 µM) and MgCl2 (200 µM). Samples were placed at 
37 °C in a heating block. After 5 min, reactions were stopped by heating at 95 °C for 5 min. 
2.4. Enzymatic assays using immobilized enzymes 
2.4.1. Enzyme immobilization on magnetic nanoparticles (MPs) 
Functionalized MPs, consisting of core-shell silica-coated iron oxide, were synthesized and 
functionalized with glutaraldehyde as described in our previous study [40]. Separate immobilization by 
cross linking of the three enzymes was performed by placing the enzyme in contact with nanoparticles, 
with a final concentration of 4 mg mL-1 of MPs diluted in phosphate buffer (50 mM, pH = 6.8) and 1.92 
g L-1 of hTK1, 0.6 g L-1 of hTMPK and 0.6 g L-1 of hNDPK. The three solutions were stirred for 7 h at 
4 °C and then stored with 1 mM glycine at 4 °C overnight. Remaining free hTK1, hTMPK and hNDPK 
was removed by successive magnetic support washings (AcNH4, 50 mM ionic strength, pH = 7). 
Nanoparticle were finally suspended in ammonium acetate buffer to obtain three immobilized enzyme 
solutions at 0.96 g L-1, 0.3 g L-1 and 0.3 g L-1 for hTK1, hTMPK and hNDPK, respectively. Final washed 
solutions showed no activity which confirmed that all non-fixed free enzymes were removed.  
 
2.4.2. Enzymatic assays - Determination of kinetic parameters of immobilized enzymes 
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FIA-HRMS assays: 7 dT solutions (from 0 to 10 000 µM), 10 dTMP solutions (from 0 to 600 µM) and 
9 dTDP solutions (from 0 to 500 µM) were incubated with hTK1, hTMPK and hNDPK at respective 
final concentrations 0.0875 g L-1, 0.004 g L-1 and 0.002 g L-1 as described in 2.3.2. After reaction and 
denaturation, immobilized enzymes were attracted by magnet and 1 µL of each supernatant was 
analyzed by FIA-HRMS. Each Michaelis-Menten assay was conducted in triplicate. 
2.5. Multi-step enzymatic reactions using FIA-HRMS 
2.5.1. Individual reaction conversion rate 
Using free enzymes, three solutions of 50 µM of dT, dTMP and dTDP ([ATP] = 350 µM, [MgCl2] = 
200 µM) were incubated with respectively free hTK1 (0.48 g L-1), free hTMPK (0.04 g L-1) and free 
hNDPK (0.04 g L-1) for 30 min at 37 °C. Similar conditions were used when working with the 
immobilized enzymes except that a 60 min incubation time was necessary for the immobilized hTK1. 
1 µL of each solution was analyzed by FIA-HRMS and each experiment was performed in triplicate.  
2.5.2. Conversion rate study of multi-step enzymatic reactions 
Enzymatic cascades were performed with and without ATP addition before each phosphorylation step 
using free and immobilized enzymes. 
Free enzymes: a solution of 50 µM of dT was placed with free hTK1 0.48 g L-1 at 37 °C for 30 min 
([ATP] = 350 µM, [MgCl2] = 200 µM). Then, the supernatant was placed with free hTMPK at a final 
concentration of 0.04 g L-1 for 30 min at 37 °C. This process was repeated with 0.04 g L-1 of free hNDPK. 
Before each enzyme addition, 1 µL of supernatant was analyzed by FIA-HRMS. Same experiment was 
performed with the addition of 350 µM of ATP before each phosphorylation step in order to evaluate 
the influence of ATP concentration in the reaction medium.  
Immobilized enzymes: multi-step enzymatic reactions were performed with immobilized enzymes by 
placing 500 µM of dT with immobilized hTK1 at 37 °C in a heating block for 1 h ([ATP] = 350 µM, 
[MgCl2] = 200 µM). Experiments with and without ATP addition before each phosphorylation step were 
performed as previously described. 
 
3. Results and discussion 
3.1. Enzymatic reaction conditions 
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Buffers, phosphodonor (ATP) and chelating agent (MgCl2) concentrations (with free and immobilized 
enzymes) and mass spectrometry detection were optimized. Reaction conditions used in biological 
assays are often incompatible with mass spectrometry detection. Usually, enzymatic reactions are 
conducted with high phosphodonor (ATP) and chelating agent (MgCl2) concentrations (around mM). 
For mass spectrometry detection, these concentrations need to be decreased to µM level. Figure 2 shows 
the high influence of phosphodonor (ATP) and chelating agent (MgCl2) concentrations on the three 
enzymatic assays. Each enzymatic conversion was significantly increased with the ATP concentration. 
At 50 µM ATP, hTK1 and hTMPK enzymes, known to be rate-limiting, show a conversion rate less 
than 30 %. Increasing ATP to 150 µM, the hNDPK enzyme shows good conversion rate whereas the 
conversion rates of hTK1 and hTMPK do not exceed 50 %. Finally, the best conversion for the three 
enzymes was obtained with 350 µM of ATP. The behaviour of the three kinases differed depending on 
the chelating agent concentration. The hTK1 enzyme seems to be more sensitive, with a conversion rate 
below 20 % of its maximum with 25 µM of Mg2+. As a compromise between reaction efficiency and 
molecule ionization in mass spectrometry, the chelating agent concentration was fixed at 200 µM. At 
this concentration, ion intensities for ATP and dTMP were respectively reduced by 45 % and 23 %. In 
this work, reactions were performed with the volatile ammonium acetate buffer and a substrate 
concentration in the range of µM. Therefore, we first evaluated the influence of this concentration 
reduction on kinase activity. Moreover, due to ionization variations and the presence of in-source 
fragmentation of phosphate groups, the FIA-HRMS methodology can bring some uncertainties in the 
quantification of the obtained products. For this, the FIA-HRMS methodology validation was performed 
by the use of two complementary methods. A spectrophotometric method (indirect detection), 
performed with co-factor concentrations around mM and µM, was first used to validate the possible 
phosphorylation monitoring with low concentrations of phosphodonor and chelating agents. Capillary 
electrophoresis technique was also used since this separative technique with UV detection offers a direct 
detection and simultaneous quantification of the substrate and the different products. This study will 
validate the kinetic parameters KM and Vmax obtained by the FIA-HRMS methodology since the 
influence of the ionization and the in-source fragmentations will be evaluated. 
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3.2. Validation of FIA-HRMS approach for kinase activity characterization using free hTMPK 
3.2.1. FIA-HRMS 
Free hTMPK kinetic study was rapidly performed by successive automatic injections in FIA mode. 1 
µL of solution was automatically injected every 30 s without needle washing between each injection. 
No memory effect was found between injections, meaning that the absence of needle washing did not 
lead to any inter-analysis contamination. This injection programming, which increase the number of 
injections in a given timespan, produced clustered kinetic points and therefore a better depiction of the 
linear zone. As shown in Figure 3, hTMPK activity was found to be linear within 6 min. For Michaelis-
Menten studies, an incubation time of 5 min was chosen to calculate the initial velocity. Values of 
catalytic efficiency obtained for hTMPK by FIA-HRMS methodology are summarized in Table 1. In 
Figure S2 is shown an example of mass spectra of dTMP conversion into dTDP.  FIA-HRMS offers 
various advantages in enzymatic activity characterisation. Due to specific compound detection, analyses 
are rapidly performed without compound separation (1 min per analysis). This specific detection by EIC 
monitoring increases method versatility and precision. 
3.2.2. UV-spectrophotometry  
Kinase activity and kinetic studies are usually conducted by UV-spectrophotometry. As show in Figure 
4, dTDP product is quantified according to a tri-enzymatic reaction, by coupling ATP consumption with 
NADH decrease. As shown in Table 1, catalytic efficiencies (kcat/KM) for both co-factor concentrations 
(µM and mM) were found to be in the same ranger; 0.05 x 105 M-1 s-1 versus 0.07 x 105 M-1 s-1. This 
confirms that hTMPK is still active using a co-factor concentration of 200 µM. These first results show 
the feasibility of kinase characterisation by FIA-HRMS with low co-factor concentrations. 
3.2.3. Capillary Electrophoresis (CE-UV) 
FIA-HRMS methodology feasibility was also validated by comparing to CE-UV [42]. As stated 
previously, FIA-HRMS methodology could bring imprecisions coming from no compound separation, 
ionisation fluctuation and in-source fragmentation. As shown in Table 1, the catalytic efficiency 
determined by CE-UV is in the same order of magnitude to the one obtained by FIA-HRMS (105 M-1 s-
1). These values of catalytic efficiencies obtained with these two direct detection methods are close to 
those previously reported in the literature [6, 43]. Therefore, FIA-HRMS methodology does not bring 
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imprecision due to no compound separation and in-source fragmentation and turned out to be reliable 
methodology for kinase kinetic studies. Although the three values are in the same order of magnitude, 
deviation between the direct detection methods (FIA-HRMS, CE-UV) and the indirect detection method 
(UV-spectrophotometry) results is expected to be due to measure deviation coming from the tri-
enzymatic reactions.  
3.3. Free and immobilized kinase activity characterization by FIA-HRMS 
Since FIA-HRMS methodology was shown suitable for hTMPK activity study it was applied to perform 
free and immobilized kinase characterization. Linearity study of free enzymes is shown in Figure 3. As 
immobilized enzymes showed lower reaction velocities, an incubation time of 5 min was chosen for 
both free or immobilized enzymes. Kinetic studies of immobilized hTK1, hTMPK and hNDPK were 
performed in triplicate. A calibration curve was realized for each Michaelis-Menten study to take into 
account any ionization influence (figure S3). Figure 5 shows the Michaelis-Menten plots for the three 
free and immobilized enzymes. KM and Vmax values are summarized in Table 2.  
Similar KM values for immobilized and free enzymes were obtained showing that the immobilization 
step does not influence enzyme affinities towards its substrate. As noted in graphs (b) and 4 (c), 
immobilized hTMPK and hNDPK showed a reaction speed decrease (Vmax divided by 2). Immobilized 
hTK1 showed the highest loss of activity with a Vmax value divided by 15. The repeatability of the hTK1 
immobilization step was studied to confirm that this high loss of activity did not come from a problem 
occurring during the immobilization process. The same hTK1 batch was immobilized three times in the 
same conditions. The KM and Vmax values were found to be similar with KM (n=3) = (7.9 ± 1.1) x 102 µM 
and Vmax (n = 3) = (7.1 ± 0.3) x 10-1 µM min-1. This loss of activity may be caused by inappropriate binding 
geometry and possible inactivation of free enzymes during the immobilization process, and by the fact 
that the concentration of the enzyme fixed to the MPs is probably lower than the concentration used for 
the immobilization process. 
Immobilized hTMPK and hNDPK activities were shown to be sufficient to conduct successive 
phosphorylation reactions. The first phosphorylation step from thymidine to thymidine monophosphate, 
catalyzed by hTK1 is shown in this work as a proof of concept.  
3.4. Multi-step enzymatic reaction 
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3.4.1. Individual reaction conversion rate 
This work is dedicated to the proof of concept of dTMP conversion into dTTP by the use of free and 
immobilized enzymes. The feasibility of an enzymatic cascade was first assessed by determining the 
conversion rate of each step using free and immobilized enzymes. The challenge was to produce a 
sufficient amount of product, above the limit of detection, to perform the next reaction. Enzyme 
concentrations used for the enzymatic cascade study are higher than used for enzyme activity 
characterisation to facilitate reaction. Substrate concentration of 25 µM was arbitrarily chosen for the 
enzymatic cascade. 
A kinetic conversion study of the accumulation of three products (dT, dTMP and dTTP) was performed 
to estimate each reaction time. Figure S4 shows the accumulation of each product as a function of time. 
As noted in Figure S4, reaction time of 30 min for immobilized hTMPK and hNDPK should allow to 
obtain maximal conversion rate. As shown in Figure 6, free enzymes showed high conversion efficiency 
with 99.6 % for hTK1, 88.6 % for hTMPK and 76.3 % for hNDPK. Conversion efficiencies of 75 % 
were obtained within 30 min for immobilized hTMPK and of 85 % for immobilized. As previously 
mentioned, immobilized hTK1 showed lower activity with 10 % conversion efficiency. The challenge 
was therefore to accumulate enough dTMP to produce the final product (dTTP).  
3.4.2. Conversion rate study of multi-step enzymatic reactions 
According to literature, hTK1 is inhibited by triphosphorylated products [44]. Therefore, the study of 
dT phosphorylation into dTTP was performed by off-line successive reaction of hTK1, hTMPK and 
hNDPK enzymes. Before studying the multi-step enzymatic reactions, the specificity of each reaction 
involving each enzyme one by one was evaluated. Each enzyme showed substrate specificity with no 
false positive conversion (< 10 %).  
To evaluate the influence of an excess of ATP on the reaction efficiency, the multi-step reaction was 
performed with and without ATP addition before each reaction (Figure 7). The amount of ATP added 
was set at 350 µM (excess of the phosphodonor).  
The incubation time for the first phosphorylation step (from dT to dTMP) was optimized to obtain the 
same amount of dTMP as that obtained with free enzymes in order to compare the enzymatic cascade 
using free and immobilized enzymes. As the immobilized hTK1 enzyme was weakly active, the initial 
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reaction was performed with a high amount of substrate and longer reaction time in order to obtain a 
sufficient amount of product for the next reaction. Of the 500 µM of dT placed with hTK1, 50 µM were 
converted into dTMP (conversion efficiency of 10 %). An excess of ATP increased conversion 
efficiencies for both free and immobilized hTMPK and hNDPK. Reaction catalyzed with free enzymes 
showed low conversion efficiencies with 3.1 µM of dTTP accumulated at the end of the multi-step 
enzymatic reaction (6.2 % of dTMP conversion efficiency). Although conversion was more efficient 
with ATP addition, conversion rates remained low and the amount of dTTP can be considered 
insignificant. As shown in Figure 7, conversion efficiencies are higher with immobilized enzymes. An 
amount of 26.0 µM of dTTP is obtained at the end of the multi-step reaction corresponding to 52 % of 
dTMP conversion efficiency. The low free enzyme efficiencies could come from high enzyme 
concentrations in solution which could lead to ionisation competition. Immobilized enzyme, removed 
from solution before analysis by magnet, could avoid these interferences. Therefore, multi-step 
enzymatic reaction study was only possible with the use of immobilized enzymes. 
This experiment proved that the enzyme immobilization methodology is suitable for multi-step 
enzymatic phosphorylation study by FIA-HRMS. It has several advantages going from removal of 
storage buffer, easy removal of enzymes from solution and increasing of enzyme stability. Although the 
first phosphorylation step was found to be rate-limiting, dTTP accumulation was proved significant in 
the case of immobilized enzymes.  
Conclusion 
This work shows for the first time the feasibility and the potential of FIA-MS methodology for the 
monitoring of nucleoside multi-step enzymatic phosphorylation. As a proof of concept, the three-
phosphorylation steps from thymidine to thymidine triphosphate were monitored using an FIA-HRMS 
methodology for a rapid and direct enzyme activity characterization as well as CE-UV. Validation was 
conducted by the Michaelis-Menten study of hTMPK using three complementary methodologies: FIA-
HRMS, UV-spectrophotometry and CE-UV. Once FIA-HRMS validated, this methodology was also 
used for immobilized hTK1, hTMPK and hNDPK activity characterisations. Both free and immobilized 
enzymes were used for the three-step phosphorylation monitoring using FIA-HRMS. However, 
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significant results were only obtained using immobilized enzymes. This study shows the interest of the 
FIA-HRMS approach for kinase activity characterization thanks to a speed of analysis (1 min per point), 
sensitive analysis (around µM) and specificity of detection (direct visualization of products). It also 
shows the potential of immobilized methodology for the monitoring of multi-enzymatic cascade notably 
in terms of the possibility to remove enzyme before the analysis of supernatant by FIA-HRMS and to 
decrease ionic suppression. This development can be applied to the study of synthetic (pro)drugs in 
order to bring better comprehension of a potential drug metabolic pathway; phosphorylation steps, 
specific activity regarding human or viral enzymatic strains… 
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Figures 
 
Figure 1: Conversion of dT, dTMP and dTDP catalyzed by hTK1, hTMPK and hNDPK 
respectively via the transfer of the γ-phosphate from phosphodonor ATP. 
 
 
Figure 2: Influence of [ATP] (50 µM, 150 µM and 350 µM) and [MgCl2] (25 µM, 200 µM, 
400 µM) on conversion efficiency of hTK1, hTMPK and hNDPK. Each value is represented as 
mean and standard deviation over 3 independent experiments. 
 
Figure 3: Time course production of dTMP (triangles, y = 0.0281x + 0.0252, R² = 0.991), dTDP 
(circles, y = 0.4566x – 0.01185, R² = 0.996) and dTTP (squares, y = 0.1228x - 0.0578, R² = 
0.995) detected by FIA-HRMS upon dT, dTMP and dTDP phosphorylation catalyzed by hTK1, 
hTMPK and hNDPK. 
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Figure 4: Spectrophotometric tri-enzymatic test for kinase activity assays 
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Figure 5: Michaelis-Menten of free (triangles) and immobilized (squares) for (a) hTK1, (b) 
hTMPK and (c) hNDPK enzymes. Each value is reported as mean and standard deviation over 
3 independent experiments. Curves obtained by GraphPad Prism 5.0 and fitted by Michaelis-
Menten equation. 
(a) (b) 
(c) 
Free 
Immobilized 
Free 
Immobilized 
Free 
Immobilized 
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Figure 6: Conversion efficiency for individual reaction catalyzed with free (light grey) and 
immobilized (dark grey). Reaction time of 30 min except for immobilized hTK1 (60 min). 
Analyses by FIA-HRMS (n = 3). 
 
 
Figure 7: Normalized amount of product accumulated (µM) for the three successive reaction 
catalyzed by (a) free and (b) immobilized hTK1, hTMPK and hNDPK. Black lines: [ATP]initial 
= 350 µM, without ATP addition between each reaction step, grey lines: [ATP]initial = 350 µM, 
with ATP addition (350 µM) between each reaction step. Each value is the mean of 3 
independent experiments. Analyses conducted by FIA-HRMS. 
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Tables 
Table 1: Catalytic efficiency (kcat/KM) of hTMPK determined by FIA-HRMS, UV-
spectrophotometry and CE-UV.  
 
  kcat/KM (M-1 s-1) 
  FIA-HRMS UV-Spectrophotometry (λ = 340 nm) CE-UV 
  [ATP] = 350 µM 
[MgCl2] = 200 µM 
[ATP] = 350 µM 
[MgCl2] = 200 µM 
[ATP] = 5 mM 
[MgCl2] = 10 mM 
[ATP] = 350 µM 
[MgCl2] = 200 µM 
hTMPK 0.21 x 105 0.05 x 105 0.07 x 105 0.48 x 105 
 
Table 2: Kinetic parameters of thymidine (dT), deoxythymidine monophosphate (dTMP), 
deoxythymidine diphosphate (dTDP) phosphorylation. Each value is the mean of 3 independent 
experiments. Analyses conducted by FIA-HRMS. 
 
 
 
 
 
Free enzymes Immobilized enzymes 
 
KM (µM) Vmax (µM min-1) KM (µM) Vmax (µM min-1) 
hTK1 (14.5 ± 2.1) x 102 9.7 ± 0.3 (7.9 ± 1.2) x 102 (7.2 ± 0.3) x 10-1  
hTMPK (3.4 ± 0.5) x 101 6.9 ± 0.5 (2.8 ± 0.4) x 101 2.9 ± 0.2 
hNDPK (9.3 ± 1.3) x 101 (1.3 ± 0.1) x 101 (1.3 ± 0.2) x 102 6.4 ± 0.4 
